A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease

Study Identifier
M14-327
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Crohn's Disease (CD)
  • Study Drug
  • ABT-494
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18 - 75 Years

    Protocol Summary

    This is a open-label extension (OLE) study designed to evaluate the long-term efficacy, safety, and tolerability of Upadacitinib (ABT-494).

    Study Locations

    Location
    Status
    Location
    UC San Diego Health System /ID# 150041
    La Jolla, California, United States, 92037
    Status
    Not applicable
    Location
    Univ California, San Francisco /ID# 149987
    San Francisco, California, United States, 94143-2204
    Status
    Not applicable
    Location
    Duplicate_University of Florida - Archer /ID# 150033
    Gainesville, Florida, United States, 32610
    Status
    Not applicable
    Location
    The Ctr for Gastro Disorders /ID# 150012
    Hollywood, Florida, United States, 33021
    Status
    Not applicable
    Location
    Nature Coast Clinical Research - Inverness /ID# 149975
    Inverness, Florida, United States, 34452-4717
    Status
    Not applicable
    Location
    Gastroenterology Associates of Central Georgia, LLC /ID# 149870
    Macon, Georgia, United States, 31201
    Status
    Not applicable
    Showing {first} - {last} of {total} Results